[Estrogen therapy of prostatic cancer. 76 cases of previously undiagnosed prostatic cancer treated with F6066 (bis-(p-acetoxyphenyl)cyclohexylidenemethane) and diethylstilbestrol--a double-blind study].
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000209:etiology; D002986:Clinical Trials as Topic; D003506:Cyclofenil / Q000009:adverse effects / Q000627:therapeutic use; D003510:Cyclohexanes / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000009:adverse effects / Q000627:therapeutic use*; D005262:Feminization / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012727:Sex Characteristics / Q000187:drug effects; D013997:Time Factors
D000970:Antineoplastic Agents; D003510:Cyclohexanes; D004054:Diethylstilbestrol; D003506:Cyclofenil
Ostrogenbehandling of cancer prostate. 76 Tilfaelde af ikke tidligere diagnostiseret cancer prostate behandlet med F6066 (bis-(p-acetoksyfenyl)ckloheksalidenemetan) og diaetylstilbøstrol--et dobbeltblindforsøg.